Christopher Haqq, Chief Medical Officer at Atara Biotherapeutics, Inc. (ATRA), sold 1,346 shares at $21.70 ($30K) on 2016-08-15, disclosed to the SEC on 2016-08-17.
Open-market sale of $30k ATRA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.70 | 400 | $9K | 28.9% |
| 2 | $22.58 | 946 | $21K | 71.1% |
| Total | $22.32 avg | 1,346 | $30K | 100% |
| Filing → |
| ATRA | SELL | 2019-02-08 | $956K | — | Filing → |
| ATRA | SELL | 2018-11-15 | $26K | — | Filing → |
| ATRA | SELL | 2018-09-27 | $582K | — | Filing → |